NO772245L - 4-hydroksyfenylalkanolaminderivater og fremgangsm}te til fremstilling av dette - Google Patents

4-hydroksyfenylalkanolaminderivater og fremgangsm}te til fremstilling av dette

Info

Publication number
NO772245L
NO772245L NO772245A NO772245A NO772245L NO 772245 L NO772245 L NO 772245L NO 772245 A NO772245 A NO 772245A NO 772245 A NO772245 A NO 772245A NO 772245 L NO772245 L NO 772245L
Authority
NO
Norway
Prior art keywords
hydroxyphenyl
procedures
preparation
alkanolamine derivatives
alkanolamine
Prior art date
Application number
NO772245A
Other languages
English (en)
Other versions
NO144848B (no
NO144848C (no
Inventor
Richard Everett Philion
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO772245L publication Critical patent/NO772245L/no
Publication of NO144848B publication Critical patent/NO144848B/no
Publication of NO144848C publication Critical patent/NO144848C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO772245A 1976-06-25 1977-06-24 Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater NO144848C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69985676A 1976-06-25 1976-06-25
US80337277A 1977-06-03 1977-06-03

Publications (3)

Publication Number Publication Date
NO772245L true NO772245L (no) 1977-12-28
NO144848B NO144848B (no) 1981-08-17
NO144848C NO144848C (no) 1981-11-25

Family

ID=27106508

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772245A NO144848C (no) 1976-06-25 1977-06-24 Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater

Country Status (21)

Country Link
JP (1) JPS5321134A (no)
AR (2) AR220896A1 (no)
AT (1) AT354420B (no)
AU (1) AU512626B2 (no)
CA (1) CA1091245A (no)
CH (2) CH627447A5 (no)
DE (1) DE2728641A1 (no)
DK (1) DK146386C (no)
ES (1) ES460040A1 (no)
FI (1) FI771976A7 (no)
FR (1) FR2366272A1 (no)
GB (1) GB1544872A (no)
HK (1) HK60184A (no)
IE (1) IE45631B1 (no)
IL (1) IL52353A (no)
LU (1) LU77604A1 (no)
NL (1) NL7707128A (no)
NO (1) NO144848C (no)
PH (2) PH15041A (no)
PT (1) PT66713B (no)
SE (1) SE7707341L (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410548A (en) 1980-07-09 1983-10-18 Reckitt & Colman Products Limited Propanolamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
FR2623804B1 (fr) * 1987-11-27 1990-03-23 Elf Aquitaine Acylation des phenols
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
DE69231100T2 (de) 1991-08-21 2001-02-15 Smith & Nephew, Inc. Flüssigkeitsbehandlungssystem
EP1051165A2 (en) 1998-01-26 2000-11-15 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
DE60008697T2 (de) * 2000-03-28 2005-02-10 Council Of Scientific And Industrial Research Verfahren zur Herstellung von 4-(P-methoxyphenyl)-2-amino-butane und Insektizide
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
TWI500600B (zh) * 2009-05-19 2015-09-21 Honshu Chemical Ind 三苯酚類及其單酯取代物之製造方法及4-醯基芳烷基苯酚衍生物
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104324977A (zh) * 2014-10-22 2015-02-04 无锡市得力手机械有限公司 一种倒立式拉丝机的卸线车
HU231124B1 (hu) * 2016-02-10 2020-12-28 Egis Gyógyszergyár Zrt. Eljárás morfológiailag egységes mirabegron és mirabegron monohidroklorid előállítására
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene

Also Published As

Publication number Publication date
DE2728641A1 (de) 1978-01-05
DK281777A (da) 1977-12-26
AR220896A1 (es) 1980-12-15
FI771976A7 (no) 1977-12-26
LU77604A1 (no) 1978-02-01
HK60184A (en) 1984-08-10
AU2636877A (en) 1979-01-04
IE45631B1 (en) 1982-10-20
DK146386B (da) 1983-09-26
AU512626B2 (en) 1980-10-23
CA1091245A (en) 1980-12-09
PT66713A (en) 1977-07-01
NO144848B (no) 1981-08-17
CH627447A5 (en) 1982-01-15
ES460040A1 (es) 1978-05-01
IE45631L (en) 1977-12-25
SE7707341L (sv) 1978-02-13
NO144848C (no) 1981-11-25
JPS5321134A (en) 1978-02-27
AT354420B (de) 1979-01-10
IL52353A (en) 1981-07-31
GB1544872A (en) 1979-04-25
FR2366272A1 (fr) 1978-04-28
PH15041A (en) 1982-05-20
AR227126A1 (es) 1982-09-30
FR2366272B1 (no) 1981-03-06
PH14332A (en) 1981-05-29
DK146386C (da) 1984-03-12
CH630068A5 (en) 1982-05-28
NL7707128A (nl) 1977-12-28
IL52353A0 (en) 1977-08-31
PT66713B (en) 1978-11-21
ATA449377A (de) 1979-06-15

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO770109L (no) Ftalanderivater og fremgangsm}te for fremstilling av disse.
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
NO772245L (no) 4-hydroksyfenylalkanolaminderivater og fremgangsm}te til fremstilling av dette
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO772229L (no) Fremgangsm}te og innretning for utveksling av hydrogenisotoper
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
RO75224A (ro) Procedeu pentru prepararea etilaminoditiocarbamatilor n-substituiti
SE7704311L (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner
NO771375L (no) Fremgangsm}te ved fremstilling av derivater av 2-iminothiazolidiner og 2-iminothiazoliner
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
DK357077A (da) Prostanderivater og fremgangsmade til fremstilling deraf
SE7705447L (sv) Forfarande for framstellning av tioetrar